MedPath

Prevacid SoluTab

These highlights do not include all the information needed to use PREVACID safely and effectively. See full prescribing information for: PREVACID (lansoprazole) Delayed-Release CapsulesPREVACID SoluTab (lansoprazole) Delayed-Release Orally Disintegrating Tablets  For oral administrationInitial U.S. Approval: 1995

Approved
Approval ID

d15c8f36-4dcc-4b28-b03c-4e81b2f9ad2e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 4, 2011

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

lansoprazole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-106
Application NumberNDA021428
Product Classification
M
Marketing Category
C73594
G
Generic Name
lansoprazole
Product Specifications
Route of AdministrationORAL
Effective DateOctober 13, 2010
FDA Product Classification

INGREDIENTS (1)

lansoprazoleActive
Quantity: 30 mg in 1 1
Code: 0K5C5T2QPG
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Prevacid SoluTab - FDA Drug Approval Details